Cancer immunology and immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
| Published in: | Springer eBooK. |
|---|---|
| Corporate Author: | |
| Other Authors: | |
| Format: | Electronic Resource |
| Language: | English |
| Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2011
|
| Series: | Issues in children's and families' lives
no.2 |
| Subjects: | |
| Online Access: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |